Hu Zijuan, Chang Xiaoman, Pan Qing, Gu Kebin, Okechukwu Patrick Nwabueze
Internal Medicine Department, Ji'ning No.1 People's Hospital, Ji'ning, Shandong Province, China.
Sleep Medical Center, Ji'ning No.1 People's Hospital, Ji'ning, Shandong Province, China.
Pharmacogn Mag. 2017 Oct-Dec;13(52):559-565. doi: 10.4103/pm.pm_135_17. Epub 2017 Nov 13.
Camel milk has been reportedly used to treat dropsy, jaundice, tuberculosis, and diabetes while camel urine is used to treat diarrhea and cancer. However, there is no scientific evidence on the antiulcer activity of camel milk and urine. Thus, the present is designed to investigate the gastroprotective and ulcer healing effect of camel milk and urine on experimentally induced gastric ulcer models in rats.
The gastroprotective effect was investigated in HCl/EtOH, water-restraint stress (WRS) and non-steroidal anti-inflammatory drugs (indomethacin)-induced ulcer models while ulcer healing activity was investigated in indomethacin-induced ulcer model. Cimetidine (100 mg/kg) was used as a standard antiulcer drug.
Acute toxicity study done up to a dosage of 10 ml/kg of camel milk and urine showed no signs of toxicity and mortality among the rats, indicating the present dosage of 5 ml/kg is safe to be administered to the rats. In the HCl/EtOH model, oral administration of cimetidine (100 mg/kg), camel urine (5 ml/kg), and camel milk (5 ml/kg) significantly ( < 0.05) inhibited gastric lesions by 83.7, 60.5 and 100%, respectively. In the WRS-induced model, cimetidine, and camel urine showed an ulcer inhibition of 100% while camel milk showed an inhibition of 50%. Similarly, in the indomethacin-induced ulcer model, cimetidine, camel milk, and urine showed an ulcer inhibition of 100, 33.3, and 66.7%, respectively. In addition, camel milk and urine also showed a significant ( < 0.05) ulcer healing effect of 100% in indomethacin-induced ulcer model, with no ulcers observed as compared to that of cimetidine, which offers a healing effect of 60.5%.
The antiulcer activity of camel milk and urine may be attributed to its cytoprotective mechanism and antioxidant properties.
Acute toxicity findings revealed the dosage of 10 ml/kg of camel milk and urine seems no toxic and indicating the dosage of 5 ml/kg is safe to be administered to the ratsOral administration of cimetidine (100 mg/kg), camel urine (5 ml/kg), and camel milk (5 ml/kg) significantly inhibited gastric lesions by 83.7, 60.5 and 100% in the HCl/EtOH experimental modelThe results of this investigation have proven that camel milk and urine showed strong ulcer healing effect in indomethacin-induced gastric damage. NSAIDs: Non-steroidal anti-inflammatory drugs, UI: Ulcer index, ANOVA: One-way analysis of variance, WRS: Water-restraint stress, ROS: Reactive oxygen species.
据报道,骆驼奶可用于治疗水肿、黄疸、肺结核和糖尿病,而骆驼尿可用于治疗腹泻和癌症。然而,目前尚无科学证据证明骆驼奶和骆驼尿具有抗溃疡活性。因此,本研究旨在探讨骆驼奶和骆驼尿对大鼠实验性胃溃疡模型的胃保护及溃疡愈合作用。
在盐酸/乙醇、水束缚应激(WRS)和非甾体抗炎药(吲哚美辛)诱导的溃疡模型中研究胃保护作用,在吲哚美辛诱导的溃疡模型中研究溃疡愈合活性。西咪替丁(100mg/kg)用作标准抗溃疡药物。
高达10ml/kg剂量的骆驼奶和骆驼尿急性毒性研究表明,大鼠未出现中毒和死亡迹象,表明5ml/kg的当前剂量对大鼠给药是安全的。在盐酸/乙醇模型中,口服西咪替丁(100mg/kg)、骆驼尿(5ml/kg)和骆驼奶(5ml/kg)分别显著(P<0.05)抑制胃损伤83.7%、60.5%和100%。在WRS诱导的模型中,西咪替丁和骆驼尿的溃疡抑制率为100%,而骆驼奶的抑制率为50%。同样,在吲哚美辛诱导的溃疡模型中,西咪替丁、骆驼奶和骆驼尿的溃疡抑制率分别为100%、33.3%和66.7%。此外,在吲哚美辛诱导的溃疡模型中,骆驼奶和骆驼尿还显示出100%的显著(P<0.05)溃疡愈合效果,与西咪替丁的60.5%愈合效果相比,未观察到溃疡。
骆驼奶和骆驼尿的抗溃疡活性可能归因于其细胞保护机制和抗氧化特性。
急性毒性研究结果显示,10ml/kg剂量的骆驼奶和骆驼尿似乎无毒,表明5ml/kg剂量对大鼠给药是安全的。在盐酸/乙醇实验模型中,口服西咪替丁(100mg/kg)、骆驼尿(5ml/kg)和骆驼奶(5ml/kg)分别显著抑制胃损伤83.7%、60.5%和100%。本研究结果证明,骆驼奶和骆驼尿对吲哚美辛诱导的胃损伤具有很强的溃疡愈合作用。NSAIDs:非甾体抗炎药,UI:溃疡指数,ANOVA:单因素方差分析,WRS:水束缚应激,ROS:活性氧。